"Considering the recent market challenges, the share price decline, and the wish from the Novo Nordisk Foundation, the Novo Nordisk Board and Lars Fruergaard Jørgensen have jointly concluded that ...

Jørgensen has agreed to stay on while the search for a successor is carried out, and the chair of the Novo Nordisk Foundation ...

Campaigners take step in legal action over toilet guidance after gender ruling - Good Law Project said on Friday that it had ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...